Phase i study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours

L. P. Martin, M. F. Kozloff, R. S. Herbst, T. A. Samuel, S. Kim, B. Rosbrook, M. Tortorici, Y. Chen, J. Tarazi, A. J. Olszanski, T. Rado, A. Starr, R. B. Cohen

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science